Searched for
KEYTRUDA BIOSIMILAR
Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...04 Sep, 2026, 07.01 PM IST- Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilarCipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...04 Sep, 2026, 10.28 AM IST
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST
- Biopharma Shakti: India targets China dependence, patent cliffIndia is launching a major initiative to boost its biopharmaceutical manufacturing. This plan aims to reduce reliance on China for crucial ...05 Feb, 2026, 07.47 AM IST
- Sun Pharma places non-binding offer for US-based Organon in its boldest global bet everSun Pharmaceutical Industries Ltd has submitted a non-binding offer to acquire US-based Organon for an all-cash deal, securing $10-14 billi...20 Jan, 2026, 06.03 AM IST
- Sun Pharma looks to rise in US with $10 billion Organon buyIndia's largest drugmaker, Sun Pharma, is considering a major acquisition. The company is evaluating the purchase of US-based Organon, a sp...19 Jan, 2026, 06.04 AM IST
- Biocon Biologics to introduce three new biosimilars for cancer treatmentBiocon Biologics will launch three new oncology biosimilars. These include Trastuzumab/Hyaluronidase, Nivolumab, and Pembrolizumab. The com...06 Jan, 2026, 07.41 PM IST
- Dr Reddy’s, Alvotech to co-develop Keytruda biosimilarDr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of Keytruda, a high...06 Jun, 2025, 10.55 AM IST
- Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda BiosimilarDr. Reddy’s Laboratories has partnered with global biotech firm Alvotech to co-develop and commercialize a biosimilar of Keytruda (pembroli...06 Jun, 2025, 09.33 AM IST
- Stocks in news: SpiceJet, JSW Energy, Bajaj Finserv, IREDA, Coal IndiaIndian stock markets are showing signs of recovery. SpiceJet is dealing with an insolvency tribunal matter. JSW Energy has commissioned a r...06 Jun, 2025, 06.33 AM IST
- Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatmentDr. Reddy's Laboratories has partnered with Alvotech to co-develop and commercialize a biosimilar for pembrolizumab (Keytruda), a crucial c...05 Jun, 2025, 01.01 PM IST
- Dr Reddy’s shares climb over 4% after Keytruda biosimilar deal with AlvotechDr. Reddy’s shares rose over 4% after announcing a global biosimilar partnership with Alvotech for Keytruda. Q4FY25 profit rose 22% YoY to ...05 Jun, 2025, 12.38 PM IST
- Big chase for a cancer drug: The urgent need for affordable Keytruda alternativesKeytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In Ind...26 Oct, 2024, 10.30 PM IST
- Will Biocon's foray into biosimilar boost its bottomline?Biological drugs are harvested from living organisms or certain components of living organisms. These drugs are very specific and highly ef...10 Aug, 2022, 12.15 PM IST
- Boehringer Ingelheim not for immuno therapy drugsA patient of a recently introduced immuno therapy drug is former US President Jimmy Carter who was treated with the drug Keytruda of Merck ...28 Apr, 2016, 03.52 AM IST
Load More
